Chemoinformaics analysis of (-)-8-Oxocanadine
Molecular Weight | 270.284 | nRot | 1 |
Heavy Atom Molecular Weight | 256.172 | nRig | 7 |
Exact Molecular Weight | 270.089 | nRing | 3 |
Solubility: LogS | -2.67 | nHRing | 2 |
Solubility: LogP | 2.47 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
No. of Oxygen atom | 4 | No. of Arom Bond | 15 |
nHA | 4 | APOL | 39.2631 |
nHD | 0 | BPOL | 19.2529 |
QED | 0.528 |
Synth | 3.467 |
Natural Product Likeliness | 2.589 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.398 |
MDCK | 0.0000217 |
BBB | 0.274 |
PPB | 0.894303 |
VDSS | 1.508 |
FU | 0.178584 |
CYP1A2-inh | 0.212 |
CYP1A2-sub | 0.72 |
CYP2c19-inh | 0.241 |
CYP2c19-sub | 0.902 |
CYP2c9-inh | 0.05 |
CYP2c9-sub | 0.695 |
CYP2d6-inh | 0.013 |
CYP2d6-sub | 0.224 |
CYP3a4-inh | 0.051 |
CYP3a4-sub | 0.278 |
CL | 13.416 |
T12 | 0.801 |
hERG | 0.009 |
Ames | 0.009 |
ROA | 0.105 |
SkinSen | 0.109 |
Carcinogencity | 0.893 |
EI | 0.872 |
Respiratory | 0.226 |
NR-Aromatase | 0.016 |
Antiviral | Yes |
Prediction | 0.656461 |